Skip to content

Ibogaine: all studies

Page 61 of 62: studies 601 to 610 of 613, newest first. Back to the ibogaine overview

Research

Effects of 18-methoxycoronaridine on acute signs of morphine withdrawal in rats.

Neuroreport May 11, 1998 B Rho, Stanley D Glick 35 citations

Ibogaine, an alkaloid found in the root bark of the African shrub Tabernanthe iboga, has been claimed to interrupt opioid dependence in humans; in animals, it has been shown to inhibit morphine self-administration and to attenuate signs of morphine withdrawal. However, ibogaine has some neurotoxicity, and because of this, efficacious and safer congeners of ibogaine have been sought,...

DOI: 10.1097/00001756-199805110-00004 (opens in new tab) Full text (opens in new tab) Opioid dependence treatment Opioid addiction therapy Opioid withdrawal management Drug dependence treatment +16

Comments on "The ketamine model of the near-death experience: A central role for the N-methyl-D-aspartate receptor".

Journal of Near-Death Studies 1997 Antonio Bianchi 1 citation

Although ketamine can induce a state similar to a near-death experience (NDE), there is a striking difference between experiences induced by ketamine used in a recreational context and in an operating room. Ketamine is a noncompetitive antagonist of the N-methyl-D-aspartate receptor, as is ibogaine, the main alkaloid of a shrub used in Central Africa to induce NDEs in a religious context....

The Use of Hallucinogens in the Treatment of Addiction

Addiction Research & Theory 1996 John H. Halpern 63 citations

AbstractResearch into treating drug dependence with hallucinogens, although promising, ended with questions still unanswered because of varying, in some cases skeptical, methodology and insufficient adherence to a double-blind, placebo-controlled design. Interest is again emerging, especially with the recent patenting in the United States of ibogaine for its apparent anti-craving properties. A...

Neocortical rhythmic slow activity during wakefulness and paradoxical sleep in rats.

Neuropsychobiology 1987 H Depoortere 14 citations

In the present study, we investigated the different types of neocortical rhythmic slow activity (RSA) during wakefulness and paradoxical sleep as well as their pharmacological modification. During wakefulness, the high-frequency (7-9 Hz) RSA1 type, which is atropine-resistant, is accentuated by forebrain stimulation and is abolished by urethane, clonidine and alcuronium. These drugs induce the...

Ethnomedical, Botanical and Phytochemical Aspects of Natural Hallucinogens

Botanical Museum leaflets Harvard University June 1, 1980 Richard Evans Schultes, Norman R. Farnsworth 23 citations

More than 200 species and/or varieties of higher plants, as well as numerous species of basidiomycetes, are reported in the literature to have been used for their hallucinatory and/or euphoriant effects.Due to a paucity of research, only a few of these have been confirmed as definitely hallucinogenic in man or animals.This article reviews all of those plants now known to have a scientific basis...

DOI: 10.5962/p.168645 (opens in new tab) Phytochemical Hallucinogen Natural archaeology Traditional medicine +1

[Modification of awake-sleep equilibrium by tabernanthine and some of its derivatives in the cat (author's transl)].

Revue d'electroencephalographie et de neurophysiologie clinique 1980 L Da Costa, I Sulklaper, R Naquet 4 citations

Intraperitoneal injections (ip.) of 4 alkaloid derivatives of ibogamine: tabernanthine tartrate (2 mg/kg), methoxy-16 ibogaine tartrate (SAD 121 - 3 mg/kg), methoxy-16 tabernanthine tartrate (SAD 122 - 2 mg/kg), and tabernanthine parachlorophenoxyacetate (SAD 103 - 7 mg/kg), were administered to chronically implanted cats. Tabernanthine tartrate and SAD 103 provoke an increase in wakefulness...

II. The Effects of Some Hallucinogens on Aggressiveness of Mice and Rats

Pharmacology 1972 Wojciech Kostowski, W Rewerski, T Piechocki 28 citations

The action of JB-336, psilocybin, ibogaine and bufotenine on the aggressiveness os isolated mice, as well as the muricide reaction of rats, was investigated. All drugs evoked a substantial decrease in aggressiveness, but this effect was dependent on isolation time, time after injection and the type of test used.

DOI: 10.1159/000136297 (opens in new tab) Psilocybin Hallucinogen Pharmacology Psychotomimetic

Lysergic Acid Diethylamide (LSD-25) as a Facilitating Agent in Psychotherapy

Archives of General Psychiatry March 1, 1960 Arthur L. Chandler 77 citations

Our use of drug-facilitated psychotherapy has been to aid repressed material to become conscious and to increase insight. Any method or tool which facilitates these processes has the possibility of being a valuable psychotherapeutic tool. Certain drugs on which we have done research, such as mescaline, ALD-52, ibogaine, psilocybin, Ditran (N-ethyl-3-piperidyl cyclopentylphenyl glycolate HC1),...

Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview.

American Journal of Therapeutics Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas et al. 12 citations

Psychedelic drugs have recently emerged as plausibly effective pharmacological agents for the management of depression, anxiety, and other neuropsychiatric conditions, including those that are treatment-resistent. The latter half of the 20th century marked a revolution in the treatment of mental illnesses, exemplified by the introduction of selective serotonin reuptake inhibitors and other...

DOI: 10.1097/mjt.0000000000001727 (opens in new tab) Full text (opens in new tab) Mental health treatment Clinical research Psychedelics Alternative medicine +1